Clinical Trials Directory

Trials / Completed

CompletedNCT04980989

Follow-up of Early Breast Cancer (BC) Patients by Telephone or Mobile Software

A Prospective Randomized Trial of Interactive Telemonitoring in the Follow-up of Patients Treated for Breast Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
765 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients with early breast cancer were randomized at the final visit of adjuvant radiotherapy to surveillance by phone calls or by mobile Noona software. After six months the groups were crossed over to the other arm. At 12 months the patients were asked their preference which was the primary end-point. At baseline, 6 months and 12 months the patients answered the other questionnaires.

Detailed description

Patients with early breast cancer were randomized at the final visit of adjuvant radiotherapy to surveillance by phone calls or by mobile Noona software. After six months the groups were crossed over to the other arm. The primary end point was to find out patient preference for the modality of surveillance. Secondary endpoints were patient satisfaction, symptoms, quality of life and cost of follow-up during surveillance modalities. At 12 months the patients were asked their preference for the follow-up modality of early breast cancer. At baseline, 6 months and 12 months the patients answered the other questionnaires on quality of life, symptoms, patient satisfaction and use of other health-care services. Information on the cost of follow-up was gathered from the hospital and other registries.

Conditions

Interventions

TypeNameDescription
DEVICEMobile software for follow-up of early breast cancerThe patients were randomized to use mobile software or telephone calls as the follow-up modality for early breast cancer

Timeline

Start date
2015-06-15
Primary completion
2021-06-15
Completion
2021-06-15
First posted
2021-07-28
Last updated
2021-07-28

Source: ClinicalTrials.gov record NCT04980989. Inclusion in this directory is not an endorsement.